Allogene Therapeutics, Inc.

NASDAQ:ALLO

Biotechnology

Healthcare
$0.74 +1.02%

+$0.02 today

Market cap
$257.81M
Beta
0.46
P/E (TTM)
-2.7
EPS (TTM)
-$0.72
52W Low $0.98High $4.46

Volume 8.49M

Average 10.19M

Price history

Allogene Therapeutics, Inc. SEC filings

Start with how the market priced the stock, then connect its moves to the disclosures filed with the SEC.

Price history

Dividend-adjusted closing price

Period change

-43.20%

Period high

$3.06

Period low

$0.74

Latest

$0.74

SEC filings

What has the company disclosed?

Browse annual, quarterly, and current reports and other filings by form type.

SEC Filings

Recent regulatory filings

FormFiling DateAccepted
SC 13GNov 10, 2026Nov 10, 2026
10-QNov 6, 2026Nov 5, 2026
8-KNov 5, 2026Nov 5, 2026
SC 13G/AOct 27, 2026Oct 27, 2026
4Oct 23, 2026Oct 23, 2026
SC 13D/ASep 30, 2026Sep 30, 2026
8-KSep 2, 2026Sep 2, 2026
4Aug 25, 2026Aug 25, 2026
EFFECTAug 20, 2026Aug 21, 2026
SC 13G/AAug 14, 2026Aug 14, 2026
10-QAug 12, 2026Aug 12, 2026
8-KAug 12, 2026Aug 12, 2026
S-3Aug 12, 2026Aug 12, 2026
SC 13GAug 7, 2026Aug 7, 2026
SC 13G/AAug 7, 2026Aug 7, 2026

Competitors

Who does Allogene Therapeutics, Inc. compete with?

Open similar companies to compare their filings and price history.

Questions

Filing questions

Common questions about ALLO's filings, answered from its disclosures.

What is the latest ALLO filing?

The latest filing shown is SC 13G dated Nov 10, 2026.

How many recent filings does ALLO have?

Intrinsic Alpha currently shows 20 recent filings for ALLO.